KPL
Kwality Pharmaceuticals Limited
Each stock's 10,000-path forecast, rendered as light.
Kwality Pharmaceuticals Limited (KPL) Stock Analysis & Case Study
Is KPL a good buy? The data-driven verdict.
Kwality Pharmaceuticals Limited (KPL) trades at ₹2,612,on the numbers it mixed signals, a Downstox Snapshot Score of 53/100.
On the numbers, Kwality Pharmaceuticals Limited (KPL) mixed signals, a Downstox Snapshot Score of 53/100, weighing premium at 39.9× earnings, ROE of 22.8%, a 50% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
KPL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How KPL ranks against the 2,373 companies in our screener
- KPL's market cap of 2,710 Cr ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KPL's book value of ₹320 ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KPL's promoter holding of 54.9% ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KPL's 3-year profit (PAT) growth of 29.0% ranks in the 68th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KPL's 3-year revenue growth of 26.0% ranks in the 81st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KPL's debt-to-equity ratio of 0.39x is lower than 43% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is KPL overvalued? KPL P/E vs peers
KPL trades at 39.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
KPL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of KPL history (49%/yr drift, 56%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| KPL 2027 | ₹1,251 | ₹2,594 | ₹5,379 | -1% |
| KPL 2028 | ₹929 | ₹2,580 | ₹7,163 | -1% |
| KPL 2029 | ₹720 | ₹2,565 | ₹9,141 | -2% |
| KPL 2030 | ₹601 | ₹2,551 | ₹10,836 | -2% |
| KPL 2031 | ₹509 | ₹2,537 | ₹12,633 | -3% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability KPL goes up, or doubles?
The bull case for KPL
- KPL's return on equity of 22.8% ranks in the 88th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KPL's return on capital employed of 24.2% ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹9,141.
The bear case & risks
- KPL's P/E of 39.9x is lower than 34% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 8.2× price-to-book means most of the value is intangible/expectations, not assets on the books.
- High historical volatility (56%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹720.
KPL volatility & expected range, how bumpy is the ride?
Over the last 9.8 years KPL compounded at 49%/year with annualized volatility of 56%. That volatility implies a 1-year 80% range of ₹1,251-₹5,379, the honest backbone behind any single price target.
KPL price forecast, the full 60-month probability fan
KPL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds KPL hits common targets within the simulated horizon?
Full multi-horizon detail on the KPL price target & forecast page.
KPL Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. KPL scores 5/8, mixed financial health.
KPL MTF margin & leverage across 7 brokers
Margin Trading Facility lets you buy KPL with part of the capital. Lower margin % = higher leverage. Rates compared across 7 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 40.19% | 2.5× |
| ZerodhaCHEAPEST | 40.14% | 2.5× |
| Groww | 40.36% | 2.5× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 41.07% | 2.4× |
| Pocketful | 40.66% | 2.5× |
| Share India | 40.30% | 2.5× |
Compare every broker on the KPL MTF page.
About Kwality Pharmaceuticals Limited: sector, index & market-cap context
Kwality Pharmaceuticals Limited (KPL) is a small-cap NSE-listed company, with a market capitalisation of ₹2,710 Cr. See more stocks on our screener.
How the KPL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Kwality Pharmaceuticals Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
KPL analysis, FAQs
Is Kwality Pharmaceuticals Limited (KPL) a good buy?
On the numbers, Kwality Pharmaceuticals Limited (KPL) mixed signals, a Downstox Snapshot Score of 53/100, weighing premium at 39.9× earnings, ROE of 22.8%, a 50% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is KPL overvalued or undervalued?
KPL trades at 39.9× earnings, premium versus the ~22× long-run Nifty average.
What is the KPL share price target for 2031?
KPL's probability-weighted 2031 median target is ₹2,537, with an 80% range of ₹509-₹12,633 (10,000-path Monte-Carlo).
What is the probability KPL doubles in 5 years?
The modelled probability of KPL reaching ₹5,218 (2×) within 5 years is 28%.
What is the bull case for KPL?
KPL's return on equity of 22.8% ranks in the 88th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. KPL's return on capital employed of 24.2% ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in KPL?
KPL's P/E of 39.9x is lower than 34% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 8.2× price-to-book means most of the value is intangible/expectations, not assets on the books. High historical volatility (56%/yr) means a wide, bumpy range of outcomes, size positions accordingly.